Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Regeneron Pharmaceuticals Inc (REGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Regeneron Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
894.14 -4.42    -0.49%
16/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
890.87
-3.27
-0.37%
8:34:52 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 578,208
  • Bid/Ask: 840.15 / 899.09
  • Day's Range: 890.43 - 901.07
Regeneron Pharma 894.14 -4.42 -0.49%

Regeneron Pharma (REGN) Earnings Dates & Reports

 
On this page, you can find detailed information about the financial performance of Regeneron, including the latest Regeneron earnings report and upcoming earnings date. The page provides an overview of the company's financial health, with key data points such as the current stock price, earnings per share, and revenue compared against the forecast.
InvestingPro Earnings Insights
Latest Release

Feb 02, 2024

EPS / Forecast

11.86 / 10.77

Revenue / Forecast

3.43B / 3.3B

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Aug 01, 2024 06/2024 -- /  11.1 -- /  3.41B
May 02, 2024 03/2024 -- /  10.14 -- /  3.23B
Feb 02, 2024 12/2023 11.86 /  10.77 3.43B /  3.3B
Nov 02, 2023 09/2023 11.59 /  10.68 3.36B /  3.23B
Aug 03, 2023 06/2023 10.24 /  9.85 3.16B /  3.03B
May 04, 2023 03/2023 10.09 /  9.56 3.16B /  3B
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View upcoming earnings forecasts and in-depth analysis of company forecasts.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

REGN Comments

Write your thoughts about Regeneron Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
양 한
양 한 Aug 24, 2023 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Scd411 is imminent
Avi Kalo
Avi Kalo Feb 03, 2023 9:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
REGN Earnings are wrong !!! it was 3.41B not M
borat smagadijev
borat smagadijev Jun 09, 2022 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Falling knife
Petet Larkar
Petet Larkar Jun 09, 2022 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I want your ******
Carmen Esparza
Carmen Esparza Jan 10, 2022 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Eliav Biton
Eliav Biton Nov 17, 2021 1:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
best opportunity in this market
Financial Advisors
Financial Advisors Nov 04, 2021 6:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
only take long positions .
David Lousada
David Lousada Nov 04, 2021 6:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
huge earnings beat!
Richard Senato
Richard Senato Sep 13, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats happening
Marut Patphol
Marut Patphol Sep 13, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fall
ken ken
ken ken Sep 13, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Most of sales in this quarters are from COVID, and competion announced results
York Regent
York Regent Aug 05, 2021 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Acquiring Inovio will propel REGN closer to COVID 19 vaccine and clear path to 1K a share.
York Regent
York Regent Aug 05, 2021 9:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This should boost Inovio. Time to pile up.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email